Form 4: Ventyx Biosciences Executive John Nuss Reports Stock Transactions

John Nuss, Chief Scientific Officer of Ventyx Biosciences, reports the vesting and disposal of restricted stock units.

Summary

• On March 28, 2025, John Nuss, the Chief Scientific Officer of Ventyx Biosciences, Inc., reported transactions involving Ventyx Biosciences common stock.
• Nuss disposed of 4,531 shares of common stock upon the vesting of restricted stock units (RSUs).
• The transaction was executed at a price of $0 per share, likely due to the shares being withheld to cover taxes or other obligations related to the RSU vesting.
• Following the reported transaction, Nuss directly owns 469,113 shares of Ventyx Biosciences common stock and 9,063 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is crucial for maintaining market integrity and investor confidence.

Stakeholder Impact

• Shareholders are informed about insider transactions, promoting transparency.

Key Dates

Keywords

Ventyx Biosciences, John Nuss, Form 4, Stock Transaction, Restricted Stock Units, VTYX, Insider Trading